Dark
Light
System
Institutional Investment Manager
ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC (CIK: 0001055951) incorporated in Delaware, located at 601 Lexington Avenue, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q2)
Portfolio Summary: 137 holdings with a total value of $9,583,046,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 BOSTON SCIENTIFIC CORP 23,129,200 540,529,000 5.64%
2 AMGEN INC 3,033,500 461,547,000 4.82%
3 ABBVIE INC 6,573,100 406,941,000 4.25%
4 BRISTOL MYERS SQUIBB CO 5,055,600 371,839,000 3.88%
5 BIOGEN INC 1,500,400 362,827,000 3.79%
6 ALEXION PHARMACEUTIC 2,981,411 348,110,000 3.63%
7 HCA HOLDINGS INC 4,098,300 315,610,000 3.29%
8 ALLERGAN PLC 1,344,615 310,727,000 3.24%
9 GILEAD SCIENCES INC 3,072,900 256,341,000 2.67%
10 CELGENE CORP 2,404,677 237,173,000 2.47%
11 WELLCARE HEALTH PLANS INC COM 1,918,500 205,817,000 2.15%
12 THERMO FISHER SCIENTIFIC INC 1,377,200 203,495,000 2.12%
13 INTUITIVE SURGICAL INC 297,800 196,968,000 2.06%
14 VERTEX PHARMACEUT 2,189,300 188,324,000 1.97%
15 INCYTE 2,324,678 185,928,000 1.94%
16 REGENERON PHARMACEUTICALS 509,900 178,072,000 1.86%
17 UNITEDHEALTH GROUP INC 1,208,200 170,598,000 1.78%
18 IMPAX LABORATORIES INC 5,886,700 169,655,000 1.77%
19 INTERCEPT PHARMACEUTICAL 1,120,000 159,802,000 1.67%
20 AGILENT TECHNOLOGIES INC 3,565,200 158,152,000 1.65%
21 PFIZER INC 4,243,700 149,421,000 1.56%
22 TEVA PHARMACEUTICAL INDS LTD 2,759,800 138,625,000 1.45%
23 RELYPSA INC 7,400,000 136,900,000 1.43%
24 IRONWOOD PHARMACEUTICALS INC COM CL A 9,949,000 130,083,000 1.36%
25 EXPRESS SCRIPTS HLDG CO 1,698,600 128,754,000 1.34%
26 MEDIVATION INC 2,001,400 120,684,000 1.26%
27 ILLUMINA INC 846,200 118,790,000 1.24%
28 BIOMARIN 1,518,500 118,139,000 1.23%
29 LILLY ELI & CO 1,476,800 116,298,000 1.21%
30 COOPER COS INC 676,300 116,033,000 1.21%
31 Wright Medical Group NV 6,545,163 113,689,000 1.19%
32 MERCK & CO INC 1,915,500 110,352,000 1.15%
33 OPHTHOTECH CORP COM 2,148,100 109,618,000 1.14%
34 ZIMMER BIOMET HLDGS INC 862,500 103,828,000 1.08%
35 JOHNSON & JOHNSON 777,600 94,323,000 0.98%
36 MOLINA HEALTHCARE INC 1,838,000 91,716,000 0.96%
37 ACHILLION PHARMACEUTICALS INC COM 11,681,600 91,116,000 0.95%
38 PUMA BIOTECHNOLOGY 2,964,025 88,298,000 0.92%
39 ALLERGAN PLC 104,200 86,859,000 0.91% PRN
40 GLAUKOS CORP 2,897,938 84,504,000 0.88%
41 NEUROCRINE BIOSCIE COM USD0.001 1,815,474 82,513,000 0.86%
42 MALLINCKRODT PUB LTD CO SHS 1,309,000 79,561,000 0.83%
43 CORVUS PHARMACEUTICALS INC COM 5,379,349 76,710,000 0.80%
44 SHIRE PLC 394,009 72,529,000 0.76%
45 MAGELLAN HEALTH INC COM NEW 1,090,600 71,729,000 0.75%
46 HUMANA 339,700 61,105,000 0.64%
47 INSYS THERAPEUTICS INC NEW COM NEW 4,688,240 60,666,000 0.63%
48 MEDTRONIC PLC 666,299 57,815,000 0.60%
49 INTELLIA THERAPEUTICS INC 2,662,180 56,838,000 0.59%
50 BLUEBIRD BIO INCORPORATED 1,185,800 51,333,000 0.54%
Page 1 of 3

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003893, filed 2016.08.15).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.